Stock Updates

Edwards Lifesciences Corp. (NYSE: EW) – Is this large market cap stock undervalued?

Edwards Lifesciences Corp. (NYSE: EW), is firmly in the large market cap category with market cap of 25075.92. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Edwards Lifesciences Corp. is 118.38 (with a change from open of 0.66%), this in conjunction with a target price of 124.9. Volume today has so far reached 456606, with an average volume of about 1158.68. The GAP for this stock, is -0.47%.

The P/E ratio is 48.89, bringing the forward P/E to a value of 34.73. The current EPS for Edwards Lifesciences Corp., is 2.42, with a EPS growth for this year coming to a value of -39.80%. Performance has been interesting with performance year to date coming to 49.61%.

Looking further into the growth statistics for Edwards Lifesciences Corp., EPS is looking like it will grow 18.33% in the next year. Looking even further it is projected to be 17.50%. Quarter over quarter is 13.70% for EPS growth and for sales growth quarter over quarter it is 23.10%. Looking at past EPS growth statistics we see that for the past five years it has been 19.70%. Sales growth for the past five years has in fact been 11.50%.

Looking at the ownership, we see that the insider ownership is at 0.30% and institutional ownership is 87.20%. Shares outstanding is 212.22, while shares float is at a value of 211.35. Float short for Edwards Lifesciences Corp. is 1.85% and the short ratio is 3.37.

In terms of debt, long term debt/equity is 0.24, while the total debt/equity comes to 0.24. The ability to meet these debts, means that the current ratio is 4.2, and the quick ratio is 3.4. The most recent gross margin is 74.30% and their operating margin is 24.40%. The profit margin is 19.30%.

Edwards Lifesciences Corp. has seen returns on assets of 13.30%, and on investment, 15.90%. Return on equity is 21.80%. Price/Earnings to growth ratio is 2.79. Price/Sales ratio is at a value of 9.14, with Price/book ratio coming to 10.14 and Price/cash is 23.65, and finally Price/Free cash Flow is 58.25.

The simple moving averages are 1.49% and 18.12% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -2.77% and the 52 week low is 64.57%.

Edwards Lifesciences Corp. has a dividend yield of *TBA, with a current price of 118.38. The ability to pay this means the payout ratio is 0.00%. This is in an industry, Medical Appliances & Equipment, with equally high dividends from other companies in this sector, which it is Healthcare. Edwards Lifesciences Corp. is based in USA.

Performance in the Medical Appliances & Equipment industry means that Edwards Lifesciences Corp. has seen performance for the past week of -1.54%, with performance for the month coming to 3.42%. Looking at the data for the quarter it is at a value of 10.40%, and for the half year the performance is 63.45%. Volatility for this week is 1.61% and for the month this is 1.61%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment